Abstract
The effects of tumor necrosis factor-α (TNF) on protein metabolism and cell-cycle kinetics were investigated in malignant tumor. Sprague-Dawley rats, subcutaneously inoculated with Walker 256 carcinosarcoma, were injected intraperitoneally with recombinant human TNF at a dose of 4.75×106 U/kg for 3 consecutive days. Tumor protein metabolism and cell-cycle kinetics were analyzed. The results showed a significant decrease in tumor volume and weight in comparison with control. TNF resulted in significant decrease in tumor protein fractional synthesis rate, protein synthesis and fractional growth rate, but no change of tumor protein fractional degradation rate. TNF also resulted in remarkable decline in labelling index and G1 phase increase of tumor cells, 6 hours after bromodeoxyuridine injection, by cytometry. The results indicated that TNF inhibits tumor growth as a result of decreases in tumor cell DNA and protein syntheses.
References
Rosenberg SA. Principles and applications of biologic therapy. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles & Practice of Oncology. 4th Ed. Philadelphia: Lippincott. 1993; 293–324.
Grunfeld C, Palladino MA Jr. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 1990; 35:45.
Tayek JA, Blackburn GL, Bistrian BR. Alterations in whole body, muscle, liver and tumor tissue protein synthesis and degradation in Novikoff hepatoma and Yoshida sarcoma tumor growthin vivo. Cancer Res 1988; 48:1554.
Jepson MM, Pell JM, Bates PC, et al. The effects of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem J 1986; 235:329.
Ye SL, Istfan NW, Driscoll DF, Bistrian BR. Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition: a study involving Walker 256 carcinosarcoma-bearing rats. Cancer 1992; 69:261.
Fogt F, Wan J, O'Hara C, et al. Flow cytometric measurement of cell cycle kinetics in rat Walker 256 carcinoma followingin vivo andin vitro pulse labelling with bromodeoxyuridine. Cytometry 1991; 12:33.
Begg AC, McNally NJ, Shrieve DC, et al. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. cytometry 1985; 6:620.
Darling G, Fraker DL, Jensen JC, et al. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res 1990; 50:4008.
Sheppard BC, Venzon D, Fraker DL, et al. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor. Cancer Res 1990; 50:3928.
Ling PR, Istfan NW, Lopes SM, et al. Structured lipid made from fish oil and medium-chain triglycerides alters tumor and host metabolism in Yoshida-sarcomabearing rats. Am J Clin Nutr 1991; 53:1177.
Tayek JA, Brasel JA. Effects of tumor necrosis factor α on skeletal muscle and Walker 256 carcinosarcoma protein metabolism studiesin vivo. Cancer Res 1990; 50:2765.
Darzynkiewicz Z, Williamson B, Carswell EA, et al. Cell cycle-specific effects of tumor necrosis factor. Cancer Res 1984; 44:83.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shenglong, Y., Zhaoyou, T. & Bistrian, B.R. Tumor necrosis factor-α alters protein metabolism and cell-cycle kinetics in malignant tumor. Chinese Journal of Cancer Research 8, 19–22 (1996). https://doi.org/10.1007/BF02674962
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02674962